Glaukos Corp (GKOS) CFO exercises options and sells 20,000 shares under 10b5-1 plan
Rhea-AI Filing Summary
Glaukos Corp senior vice president and chief financial officer Alex R. Thurman reported an options exercise and same-day sale of common stock. On August 7, 2026, he exercised stock options for 20,000 shares of common stock at an exercise price of $33.81 per share and acquired those shares, then sold 20,000 shares of common stock at a weighted average price of $180.13 per share in a sale in open market or private transactions. The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted on December 15, 2025. Following these transactions, his reported holdings include 5,230 restricted stock units that have not yet vested or been delivered and 225 stock units purchased through the Employee Stock Purchase Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F4, F5 | 20,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 20,000 | $33.81 | $676K |
| Sale | Common Stock F2, F3, F1 | 20,000 | $180.13 | $3.60M |
Footnotes (5)
- F1. Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
- F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
- F3. This transaction was executed in multiple trades at prices ranging from $180.00 to $180.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
- F5. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
restricted stock units financial
Employee Stock Purchase Plan financial
weighted average price financial
Stock Option (Right to Buy) financial
FAQ
What insider transactions did Glaukos (GKOS) CFO Alex R. Thurman report?
Were the recent GKOS insider trades by the CFO under a Rule 10b5-1 plan?
What equity awards does the Glaukos (GKOS) CFO still hold after these transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.